Repressive Effect of Primary Virus Replication on Superinfection Correlated with Gut-Derived Central Memory CD4+ T Cells in SHIV-Infected Chinese Rhesus Macaques

A possible mechanism of susceptibility to superinfection with simian-human immunodeficiency virus (SHIV)-1157ipd3N4 was explored in twelve SHIVSF162P3-infected Chinese rhesus macaques. Based on the kinetics of viral replication for the second infecting virus following SHIV-1157ipd3N4 inoculation, the monkeys were divided into two groups: those relatively resistant to superinfection (SIR) and those relatively sensitive to superinfection (SIS). We found that superinfection-resistant macaques had high primary viremia, whereas superinfection-sensitive macaques had low primary viremia, suggesting that primary SHIVSF162P3 infection with a high viral-replication level would repress superinfection with a heterologous SHIV-1157ipd3N4. Although no correlation of protection against superinfection with virus-specific CD4+ T cell or CD8+ T cell immune responses from gut was observed prior to superinfection, superinfection susceptibility was strongly correlated with CD4+ Tcm cells from gut both prior to the second infecting virus inoculation and on day 7 after superinfection, but not with CD4+ Tem cells from gut or with CD4+ Tcm cells from peripheral blood and lymph node. These results point to the important roles of gut-derived CD4+ Tcm cells for the study of the mechanisms of protection against superinfection and the evaluation of the safety and efficacy of vaccines and therapies against acquired immune deficiency syndrome (AIDS).

[1]  C. Qin,et al.  Circulating IL-21 levels increase during early simian-human immunodeficiency virus infection in macaques , 2013, Archives of Virology.

[2]  Y. Shao,et al.  Partial protection of SHIV-infected Chinese rhesus macaques against super-infection with heterologous SHIV isolate. , 2012, Current HIV research.

[3]  P. Hraber,et al.  HIV-1 subtype C superinfected individuals mount low autologous neutralizing antibody responses prior to intrasubtype superinfection , 2012, Retrovirology.

[4]  A. Nadas,et al.  Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus , 2012, Retrovirology.

[5]  A. Gettie,et al.  An Intravaginal Ring That Releases the NNRTI MIV-150 Reduces SHIV Transmission in Macaques , 2012, Science Translational Medicine.

[6]  W. Heneine,et al.  Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis. , 2012, The Journal of infectious diseases.

[7]  D. Montefiori,et al.  Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines , 2012, Nature Medicine.

[8]  Yufei Wang,et al.  Immunization with recombinant macaque major histocompatibility complex class I and II and human immunodeficiency virus gp140 inhibits simian-human immunodeficiency virus infection in macaques. , 2012, The Journal of general virology.

[9]  C. Cheng‐Mayer,et al.  Pathogenic Consequences of Vaginal Infection with CCR5-Tropic Simian-Human Immunodeficiency Virus SHIVSF162P3N , 2012, Journal of Virology.

[10]  R. McClelland,et al.  Cellular immune responses and susceptibility to HIV-1 superinfection: a case–control study , 2012, AIDS.

[11]  L. Waters,et al.  HIV-1 superinfection , 2012, Current opinion in infectious diseases.

[12]  M. Cornelissen,et al.  HIV-1 dual infection is associated with faster CD4+T cell decline in a cohort of men with primary HIV infection , 2011, Retrovirology.

[13]  G. Towers,et al.  Early Potent Protection against Heterologous SIVsmE660 Challenge Following Live Attenuated SIV Vaccination in Mauritian Cynomolgus Macaques , 2011, PloS one.

[14]  O. Laeyendecker,et al.  Identification of HIV Superinfection in Seroconcordant Couples in Rakai, Uganda, by Use of Next-Generation Deep Sequencing , 2011, Journal of Clinical Microbiology.

[15]  L. Lopalco,et al.  Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges. , 2011, Immunity.

[16]  J. Allan,et al.  Relative replication capacity of phenotypic SIV variants during primary infections differs with route of inoculation , 2010, Retrovirology.

[17]  B. Berkhout,et al.  Analysis of infectious virus clones from two HIV-1 superinfection cases suggests that the primary strains have lower fitness , 2010, Retrovirology.

[18]  Wei Zhang,et al.  Deglycosylation of FcalphaR at N58 increases its binding to IgA. , 2010, Glycobiology.

[19]  Lian Shen,et al.  Ectodomain shedding of Fcα receptor is mediated by ADAM10 and ADAM17 , 2010, Immunology.

[20]  M. Zhong,et al.  Induction of balance and breadth in the immune response is beneficial for the control of SIVmac239 replication in rhesus monkeys. , 2010, The Journal of infection.

[21]  H. Xing,et al.  Alteration of serotonin transporter messenger RNA level in the peripheral blood mononuclear cells from simian/human immunodeficiency virus infected Chinese rhesus macaques (Macaca mulatta) , 2010, Brain, Behavior, and Immunity.

[22]  J. Petravic,et al.  Is the Gut the Major Source of Virus in Early Simian Immunodeficiency Virus Infection? , 2009, Journal of Virology.

[23]  D. Montefiori,et al.  Control of viremia and maintenance of intestinal CD4(+) memory T cells in SHIV(162P3) infected macaques after pathogenic SIV(MAC251) challenge. , 2009, Virology.

[24]  B. Korber,et al.  Partial Protection of Simian Immunodeficiency Virus (SIV)-Infected Rhesus Monkeys against Superinfection with a Heterologous SIV Isolate , 2009, Journal of Virology.

[25]  S. Kent,et al.  Low pre-infection levels and loss of central memory CD4+ T cells may predict rapid progression in SIV-infected pigtail macaques. , 2008, Virology.

[26]  D. Burton,et al.  Macaques vaccinated with live-attenuated SIV control replication of heterologous virus , 2008, The Journal of experimental medicine.

[27]  B. Chohan,et al.  Human Immunodeficiency Virus Type 1 Superinfection Occurs despite Relatively Robust Neutralizing Antibody Responses , 2008, Journal of Virology.

[28]  R. Cheynier,et al.  Persistence of restricted CD4 T cell expansions in SIV-infected macaques resistant to SHIV89.6P superinfection. , 2008, Virology.

[29]  S. Staprans,et al.  Severe Depletion of Mucosal CD4+ T Cells in AIDS-Free Simian Immunodeficiency Virus-Infected Sooty Mangabeys1 , 2007, The Journal of Immunology.

[30]  T. Matano,et al.  Induction of CD8+ Cells Able To Suppress CCR5-Tropic Simian Immunodeficiency Virus SIVmac239 Replication by Controlled Infection of CXCR4-Tropic Simian-Human Immunodeficiency Virus in Vaccinated Rhesus Macaques , 2007, Journal of Virology.

[31]  D. Richman,et al.  Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. , 2006, Virology.

[32]  H. McClure,et al.  Molecularly Cloned SHIV-1157ipd3N4: a Highly Replication- Competent, Mucosally Transmissible R5 Simian-Human Immunodeficiency Virus Encoding HIV Clade C env , 2006, Journal of Virology.

[33]  A. Perelson,et al.  Influence of Peak Viral Load on the Extent of CD4+ T-Cell Depletion in Simian HIV Infection , 2006, Journal of acquired immune deficiency syndromes.

[34]  G. Hale,et al.  CD8+ Lymphocytes Do Not Mediate Protection against Acute Superinfection 20 Days after Vaccination with a Live Attenuated Simian Immunodeficiency Virus , 2005, Journal of Virology.

[35]  Qingsheng Li,et al.  Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells , 2005, Nature.

[36]  Mario Roederer,et al.  Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection , 2005, Nature.

[37]  D. Price,et al.  CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.

[38]  J. Heeney,et al.  Macaques infected long-term with attenuated simian immunodeficiency virus (SIVmac) remain resistant to wild-type challenge, despite declining cytotoxic T lymphocyte responses to an immunodominant epitope. , 2004, The Journal of general virology.

[39]  B. Branson,et al.  Virological evaluation of the ‘Ottawa case’ indicates no evidence for HIV-1 superinfection , 2004, AIDS.

[40]  J. Robinson,et al.  Antigenic variations in the CD4 induced sites of the CCR5‐tropic, pathogenic SHIVsf162p3 gp120 variants , 2003, Journal of medical primatology.

[41]  R. Desrosiers,et al.  Mucosal Priming of Simian Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Responses in Rhesus Macaques by the Salmonella Type III Secretion Antigen Delivery System , 2003, Journal of Virology.

[42]  J. Lifson,et al.  SIVmac pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans , 2002, AIDS.

[43]  D. Watkins,et al.  Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239 , 2002, Journal of Virology.

[44]  D. Ho,et al.  CD4+ lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic Simian/Human Immunodeficiency Virus (SHIV). , 2002, Journal of acquired immune deficiency syndromes.

[45]  John P. Moore,et al.  AIDS vaccine models: Challenging challenge viruses , 2002, Nature Medicine.

[46]  Shiu-Lok Hu,et al.  Evidence for Early Local Viral Replication and Local Production of Antiviral Immunity upon Mucosal Simian-Human Immunodeficiency Virus SHIV89.6 Infection in Macaca nemestrina , 2001, Journal of Virology.

[47]  Z. Hel,et al.  Differences in time of virus appearance in the blood and virus-specific immune responses in intravenous and intrarectal primary SIVmac251 infection of rhesus macaques; a pilot study , 2001, BMC infectious diseases.

[48]  C. Cheng‐Mayer,et al.  Mucosal Transmission and Induction of Simian AIDS by CCR5-Specific Simian/Human Immunodeficiency Virus SHIVSF162P3 , 2001, Journal of Virology.

[49]  D. Ho,et al.  Enhanced Infectivity of an R5-Tropic Simian/Human Immunodeficiency Virus Carrying Human Immunodeficiency Virus Type 1 Subtype C Envelope after Serial Passages in Pig-Tailed Macaques (Macaca nemestrina) , 2000, Journal of Virology.

[50]  C. Cheng‐Mayer,et al.  Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. , 1999, Science.

[51]  J. Skurnick,et al.  Lack of infection in HIV-exposed individuals is associated with a strong CD8(+) cell noncytotoxic anti-HIV response. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[52]  D. Ho,et al.  Temporal Analyses of Virus Replication, Immune Responses, and Efficacy in Rhesus Macaques Immunized with a Live, Attenuated Simian Immunodeficiency Virus Vaccine , 1998, Journal of Virology.

[53]  S. Dandekar,et al.  Intestinal Intraepithelial Lymphocytes Are Primed for Gamma Interferon and MIP-1β Expression and Display Antiviral Cytotoxic Activity despite Severe CD4+ T-Cell Depletion in Primary Simian Immunodeficiency Virus Infection , 1998, Journal of Virology.

[54]  R P Johnson,et al.  Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. , 1998, Science.

[55]  R. B. Swenson,et al.  Superinfection of a chimpanzee with a second strain of human immunodeficiency virus , 1987, Journal of virology.

[56]  R. Siliciano,et al.  HIV-1-induced depletion of CD4+ T cells in the gut: mechanism and therapeutic implications. , 2006, Trends in pharmacological sciences.

[57]  Philip R. Johnson,et al.  HIV vaccine design: insights from live attenuated SIV vaccines , 2005, Nature Immunology.